Beam Therapeutics *
Beam Therapeutics is a biotechnology company pioneering precision genetic medicines through base editing, a technology that makes precise, predictable, and efficient single-base changes to the genome without cutting the DNA double helix. The company is developing a portfolio of investigational base editing programs across hematology, hepatology, and other therapeutic areas, using multiple delivery modalities including electroporation, nonviral lipid nanoparticles, and viral vectors. Publicly traded on Nasdaq as BEAM, Beam was named a TIME100 Most Influential Company in 2026. This profile was surfaced as a portfolio company of gv and hongshan; it is a life-sciences company with no public developer/API surface at this time.
Beam Therapeutics * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Genetic Medicine, and Base Editing.
Beam Therapeutics *’s developer surface includes support and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API